Assist. Prof. Dr. Mohamed skiba | Pharmaceutics Award | Best Innovation Award

Posted on by ScienceFather

Assist. Prof. Dr. Mohamed skiba | Pharmaceutics Award | Best Innovation Award

Assist. Prof. Dr. Mohamed skiba, University of rouen, France

Dr. Mohamed Skiba, is a French national and a distinguished pharmaceutical scientist. He is a lecturer at the Faculty of Medicine and Pharmacy in Rouen, where he leads the Pharmaceutical Team within the Galenic Group. Dr. Skiba earned his Ph.D. in Pharmaceutical Sciences from the University of Paris XI in 1994 and has been active in pharmaceutical research since 1990, focusing on cyclodextrin and drug vectorization. With over 140 international publications, 80 patents, and numerous contributions to books and congresses, he is a recognized expert in pharmaceutical technology. Dr. Skiba is also an active member of several scientific societies, including the French Society of Chemistry and the French Association of Teachers of Technological Pharmacy. He is fluent in French, English, and Arabic.

Professional Profile:

Orcid

Suitability for Best Innovation Award: Dr. Mohamed SKIBA

Dr. Mohamed Skiba’s extensive work in pharmaceutical sciences, particularly his research in drug formulation and cyclodextrin technologies, positions him as a strong candidate for the Best Innovation Award. His innovations, reflected in his numerous patents and publications, highlight his ability to drive pharmaceutical advancements with real-world applications. His leadership in academic and research institutions further amplifies his impact, making him a deserving recipient of this prestigious award.

🎓Education:

Dr. Mohamed Skiba holds a Ph.D. in Pharmaceutical Sciences, which he earned in 1994 from the University of Paris XI, Southern Paris. His academic journey also includes a Diploma of Thorough Studies in Pharmacotechnology and Biopharmacy (1990) from the University of Paris XI in Châtenay-Malabry. In 1990, he obtained a Diploma in Veterinary Pharmaceuticals from the Faculty of Pharmacy, University of Clermont-Ferrand I. Additionally, Dr. Skiba completed advanced studies in pharmacology and electrophysiology with a Control of Research degree from the University of Poitiers in 1989. He also pursued studies in patent rights at the Faculty of Orsay, University of Paris-South, enriching his expertise in pharmaceutical and intellectual property matters.

🏢Work Experience:

Dr. Mohamed Skiba has been a lecturer at the Faculty of Medicine and Pharmacy, University of Rouen, France, since 1998. In this role, he teaches courses in galenic and industrial galenic pharmacy to both undergraduate and graduate students, while also leading the Pharmaceutical Team within the Galenic Group. His professional experience includes serving as a trainee at the Central Pharmacy of the Hospitals of Paris (PCH) and working as an Associated Attaché in Toxicology and Clinical Pharmacology at the Hospital of Corbeil-Essonnes, further enhancing his expertise in pharmaceutical technology and clinical applications.

🏅Awards & Recognition:

Dr. Mohamed Skiba is a prolific contributor to the field of pharmaceutical technology, holding over 80 patents that highlight his innovative work. He has authored 140 international publications and contributed to 9 book chapters, making significant scholarly impacts. Additionally, Dr. Skiba has presented 71 communications at prestigious scientific congresses, sharing his research and advancements with the global scientific community.

🔬Research Focus:

Dr. Skiba’s research primarily centers on pharmaceutical technology, with a particular focus on cyclodextrin and drug vectorization. His work involves improving drug delivery systems, studying bio-polymeric materials, and developing innovative pharmaceutical formulations. He has been involved in numerous pharmaceutical research projects since 1990, contributing to the advancement of drug delivery and formulation technologies.

Publication Top Notes:

  • Powder Self-Emulsifying Drug Delivery System for Mitotane: In Vitro and In Vivo Evaluation
  • In vitro dissolution of encapsulated or dispersed vitamin E and cholesterol is correlated with preservation of refrigerated ovine sperm
  • Exploring the Therapeutic Potential of Algerian Propolis: GC/MS Profiling, Protective Inclusion Complex, and In Silico Evaluation Against SARS‐CoV‐2 Main Proteases
  • Development of a Novel Cyclodextrin–Chitosan Polymer for an Efficient Removal of Pharmaceutical Contaminants in Aqueous Solution

 

 

Prof. Dr. HITENDRA MAHAJAN | Pharmaceutics Award | Best Researcher Award

Posted on by ScienceFather

Prof. Dr. HITENDRA MAHAJAN | Pharmaceutics Award | Best Researcher Award

Prof. Dr. HITENDRA MAHAJAN, R C Patel Instituted of Pharmaceutical Education and Research Shiprpur, India

Hitendra S. Mahajan, with a background in pharmacy including a Ph.D., brings over 22 years of experience in academia and scientific research. He is currently serving as a Professor at R.C. Patel Institute of Pharmaceutical Education and Research (IPER) in Shirpur, where he has held various teaching positions since 1998. Mahajan’s expertise lies in the development and evaluation of drug delivery systems, particularly in nasal mucoadhesive formulations. He has secured significant funding for his research projects, totaling over 142 lakhs, and has been involved in sponsored projects as both Principal Investigator and Co-Investigator. With a strong academic portfolio, Mahajan holds leadership roles in various capacities, including Head of the Department of Pharmaceutics and Head of Training and Placement. He has received numerous awards and honors for his research contributions, including Research Excellence Awards from the University Grant Commission and Association of Pharmacy Teachers, India (APTI). Mahajan’s commitment to advancing pharmaceutical sciences is evident through his active involvement in academic and research endeavors, as well as his dedication to training future professionals in the field.

Professional Profile:

Scopus

Orcid

Google Scholar

🎓 Academic Achievements:

Hitendra S. Mahajan pursued his Ph.D. at North Maharashtra University, Jalgaon (M.S.), focusing on the “Formulation and Evaluation of Nasal Mucoadhesive Drug Delivery System.” Under the guidance of Dr. S. G. Gattani, Mahajan conducted groundbreaking research in this area, contributing significantly to advancements in pharmaceutical science. His work exemplifies his dedication to innovative drug delivery systems and his commitment to academic excellence.

📚 Academic Portfolios/Responsibilities:

Hitendra S. Mahajan is a multifaceted academician who serves in various leadership roles within the academic community. He holds the esteemed positions of Head of the Department of Pharmaceutics and Head of Training and Placement at R.C. Patel IPER Shirpur. Additionally, Mahajan plays pivotal roles as the Course Coordinator for the Certificate course in DRA and IPR, President of the Institute Innovation Council Cell, and Coordinator for both the National Institute Ranking Framework (NiRF) and Atal Ranking of Institutions on Innovation Achievements (ARIIA). He also oversees the Incubation Center and coordinates the KAPILA program, demonstrating his commitment to fostering innovation and excellence in education.

🎓 Professional Details:

With over 22 years of experience in academia and research, Hitendra S. Mahajan currently holds the esteemed position of Professor at R.C. Patel IPER Shirpur. His expertise lies in the development of drug delivery systems, where he has honed his skills in handling a myriad of instruments including particle size analyzers, tablet presses, Brookfield viscometers, and more. Having completed his Ph.D. on the topic of “Formulation and Evaluation of Nasal Mucoadhesive Drug Delivery System” under the guidance of Dr. S. G. Gattani at North Maharashtra University, Jalgaon, Mahajan has established himself as a distinguished figure in the field.

🔬 Research Projects:

Hitendra S. Mahajan has served as a Principal Investigator for numerous sponsored projects, securing funding totaling 122.19 lakh (approximately 161,500 USD). His leadership and expertise have been instrumental in overseeing these projects, which have contributed significantly to the field of pharmaceutical research. Additionally, Mahajan has been involved as a Co-Investigator in sponsored projects totaling 21.27 lakh, further demonstrating his collaborative approach to research and his ability to work effectively within interdisciplinary teams to achieve research objectives.

🏆 Awards & Honors:

Hitendra S. Mahajan has been honored with numerous prestigious awards, including Research Awards, the Nation Builder Award, and the Research Initiative Award, among others. These accolades serve as recognition of his outstanding contributions to the field of pharmaceutical research and his significant impact on academia and society. Mahajan’s dedication, innovation, and commitment to excellence have earned him the respect and admiration of his peers, making him a respected figure in the pharmaceutical community.

Publication Top Notes: